Lower rates of hypoglycaemia in older individuals with type 2 diabetes using insulin degludec versus insulin glargine U100: Results from SWITCH 2.

Simon R Heller J Hans DeVries Carol H WyshamCharlotte T HansenMelissa V HansenBrian M Frier

Published in: Diabetes, obesity & metabolism (2019)

Treatment with degludec was safe and effective, with a frequency of hypoglycaemia lower than that with glargine U100 in both younger and older individuals (>65 years) with T2D.

Keyphrases

type diabetes
glycemic control
community dwelling
physical activity
middle aged
insulin resistance
weight loss
combination therapy
skeletal muscle